The role of "eye platelet rich plasma" (E-Prp) for wound healing in ophthalmology

Current Pharmaceutical Biotechnology

Volumn 13, Issue 7, 2012, Pages 1257-1265

  Alió, Jorge L ^a,b   Arnalich Montiel, Francisco ^a  

^a VISSUM Corporacion Oftalmologica   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Corneal dormant ulcer; Corneal perforations; Dry eye; Eye platelet rich plasma; Ocular surface syndrome post LASIK

Indexed keywords

CELL ADHESION MOLECULE; EYE DROPS; GROWTH FACTOR;

AMNIOTIC MEMBRANE TRANSPLANTATION; CORNEA; CORNEA EPITHELIUM; CORNEA PERFORATION; CORNEA ULCER; DISEASE ASSOCIATION; DISEASE SEVERITY; DISPOSABLE EQUIPMENT; DRY EYE; EYE INFLAMMATION; EYE PAIN; EYE PLATELET RICH PLASMA; EYE SURGERY; HUMAN; KERATOMILEUSIS; LAMINAR FLOW; OCULAR SURFACE DISEASE; OPHTHALMOLOGY; PEER REVIEW; PHOTOPHOBIA; REVIEW; THROMBOCYTE; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; TREATMENT OUTCOME; VISUAL ACUITY; WOUND HEALING;

EID: 84861148324     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112800624355     Document Type: Review

References (50)

1. Fox, R.I.; Chan, R.; Michelson, J.B.; Belmont J.B.; Michelson, P.E. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum., 1984, 27(4), 459-461.
2. Matsumoto, Y.; Dogru, M.; Goto, E.; Ohashi, Y.; Kojima, T.; Ishida, R.; Tsubota, K. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology, 2004, 111(6), 1115-1120.
3. Tsubota, K.; Satake, Y.; Ohyama, M.; Toda, I.; Takano, Y.; Ono, M.; Shinozaki, N.; Shimazaki, J. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am. J. Ophthalmol., 1996, 122(1), 38-52.
4. Dua, H. S.; Azuara-Blanco, A. Amniotic membrane transplantation. Br. J. Ophthalmol., 1999, 83(6), 748-752.
5. Azuara-Blanco, A.; Pillai, C.T.; Dua, H.S. Amniotic membrane transplantation for ocular surface reconstruction. Br. J. Ophthalmol., 1999, 83(4), 399-402.
6. Kojima, T.; Higuchi, A.; Goto, E.; Matsumoto, Y.; Dogru, M.; Tsubota, K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea, 2008, 27(Suppl 1), S25-30.
7. Anitua, E.; Andia, I.; Ardanza, B.; Nurden, P.; Nurden, A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost., 2004, 91(1), 4-15.
8. Tsubota, K.; Goto, E.; Shimmura, S.; Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology, 1999, 106(10), 1984-1989.
9. Goto, E.; Shimmura, S.; Shimazaki, J.; Tsubota, K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea, 2001, 20(8), 807-810.
10. Ogawa, Y.; Okamoto, S.; Mori, T.; Yamada, M.; Mashima, Y.; Watanabe, R.; Kuwana, M.; Tsubota, K.; Ikeda, Y.; Oguchi, Y. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant., 2003, 31(7), 579-583.
11. Noda-Tsuruya, T.; Asano-Kato, N.; Toda, I; Tsubota, K. Autologous serum eye drops for dry eye after LASIK. J. Refract. Surg., 2006, 22(1), 61-66.
12. Tsubota, K.; Shimazaki, J. Surgical treatment of children blinded by Stevens-Johnson syndrome. Am. J. Ophthalmol., 1999, 128(5), 573-581.
13. Liu, L.; Hartwig, D.; Harloff, S.; Herminghaus, P.; Wedel, T.; Kasper, K.; Geerling, G. Corneal epitheliotrophic capacity of three different blood-derived preparations. Invest. Ophthalmol. Vis. Sci., 2006, 47(6), 2438-2444.
14. Anitua, E.; Sánchez, M.; Nurden, A.T.; Nurden, P.; Orive, G.; Andía, I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol., 2006, 24(5), 227-234.
15. Nurden, A.T.; Nurden, P.; Sánchez, M.; Andía, I.; Anitua, E. Platelets and wound healing. Front. Biosci., 2008, 13, 3532-3548.
16. Marx, R.E. Platelet-rich plasma: evidence to support its use. J. Oral Maxillofac. Surg., 2004, 62(8), 489-496.
17. Anitua, E.; Andía, I.; Sánchez, M.; Azofra, J.; Zalduendo, M.;, De la Fuente, M.; Nurden, P.; Nurden, A.T. Autologous preparations Rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J. Orthop. Res., 2005, 23(2), 281-286.
18. Anitua, E.; Sánchez, M.; Nurden, A.T.; Zalduendo, M.; de la Fuente, M.; Azofra, J.; Andía, I. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology, 2007, 46(12), 1769-1772.
19. Anitua, E.; Sánchez, M.; Zalduendo, M.M.; de la Fuente, M.; Prado, R.; Orive, G.; Andía, I. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif., 2009, 42(2), 162-170.
20. Anitua, E. Plasma rich in growth factors: preliminary results of use in the preparation of sites for implants. Int. J. Oral Maxillofac. Implants, 1999, 14(4), 529-535.
21. Anitua, E. (2001) The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent., 2001, 13(6), 487-493.
22. Anitua, E.; Sánchez, M.; Orive, G.; Andía, I. The potential effects of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials, 2007, 28(31), 4551-4560.
23. Marx, R.E. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent., 2001, 10(4), 225-228.
24. Foster, T.E.; Puskas, B.L.; Mandelbaum, B.R.; Gerhardt, M.B.; Rodeo, S.A. Platelet-rich plasma: from basic science to clinical applications. Am. J. Sports Med., 2009, 37(11), 2259-2272.
25. Intini, G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials, 2009, 30(28), 4956-4966.
26. Anitua, E.; Orive, G.; Pla, R.; Roman, P.; Serrano, V.; Andía, I. The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study. J. Biomed. Mater. Res. A., 2009, 91(1), 158-165.
27. Roldan, J.C.; Jepsen, S.; Schmidt, C.; Knüppel, H.; Rueger, D.C.; Açil, Y.; Terheyden, H. Sinus floor augmentation with simultaneous placement of dental implants in the presence of platelet-rich plasma or recombinant human bone morphogenetic protein-7. Clin. Oral Implants Res., 2004, 15(6), 716-723.
28. Garg, A.K.; Gargenese, D.; Peace, I. Using platelet-rich plasma to develop an autologous membrane for growth factor delivery in dental implant therapy. Dent. Implantol. Update, 2000, 11(6), 41-44.
29. Sánchez, M.; Anitua, E.; Azofra, J.; Aguirre, J.J.; Andia, I. Intraarticular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin. Exp. Rheumatol., 2008, 26(5), 910-913.
30. Sánchez, M.; Anitua, E.; Azofra, J.; Andía, I.; Padilla, S.; Mujika, I. Comparison of surgically repaired Achilles tendon tears using PRGF. Am. J. Sports Med., 2007, 35(2), 245-251.
31. Anitua, E.; Aguirre, J.J.; Algorta, J.; Ayerdi, E.; Cabezas, A.I.; Orive, G.; Andia, I. Effectiveness of autologous preparation-rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed. Mat. Res. B., 2008, 84(2), 415-421.
32. Blumenkranz, M.S.; Ohana, E.; Shaikh, S.; Chang, S.; Coll, G.; Morse, L.S.; De Bustros, S. Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange. Ophthalmic. Surg Lasers, 2001, 32(3), 198-207.
33. Man, D.; Plosker, H.; Winland-Brown, J.E. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast. Reconstr. Surg., 2001, 107(1), 229-237.
34. Mazor, Z.; Peleg, M.; Garg, A.K.; Luboshitz, J. Platelet-rich plasma for bone graft enhancement in sinus floor augmentation with simultaneous implant placement: patient series study. Implant Dent., 2004, 13(1), 65-72.
35. Velich, N.; Nemeth, Z.; Hrabak, K.; Suba, Z.; Szabo, G. Repair of bony defect with combination biomaterials. J. Craniofac. Surg., 2004, 15(1), 11-15.
36. Siebrecht, M.A.; De Rooij, P.P.; Arm, D.M.; Olsson, M.L.; Aspenberg, P. Platelet concentrate increases bone ingrowth into porous hydroxyapatite. Orthopedics, 2002, 25(2), 169-72.
37. Lieberman, J.R.; Daluiski, A.; Einhorn, T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J. Bone Joint Surg. Am., 2002, 84-A(6), 1032-1044.
38. Anitua, E.; Sánchez, M.; Orive, G.; Andía, I. PRGF technology: a biological delivery system of growth factors. Trends Pharmacol. Science, 2008, 29(2), 37-41.
39. Anitua, E.; Sánchez, M.; Orive, G.; Andía, I. Shedding light in the controversial terminology for platelet rich products. J. Biomed. Mater. Res. A., 2009, 90(4), 1262-1263.
40. Alio, J.L.; Pastor, S.; Ruiz-Colecha, J.; Rodriguez, A.; Artola, A. Treatment of ocular surface syndrome after LASIK with autologous platelet-rich plasma. J. Refract. Surg., 2007, 23(6), 617-619.
41. Alio J. L; Abad M.; Artola A.; Rodriguez-Prats J.L.; Pastor S.; Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology, 2007, 114(7), 1286-1293.
42. Pflugfelder, S. C.; Wilhelmus, K. R.; Osato, M. S.; Matoba, A. Y.; Font, R. L. The autoimmune nature of aqueous tear deficiency. Ophthalmology, 1986, 93(12), 1513-1517.
43. Pepose, J.S.; Akata, R.F.; Pflugfelder, S. C; Voigt, W. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjogren's syndrome. Ophthalmology, 1990, 97(12), 1599-1605.
44. Alio, J.L.; Colecha, J.R.; Pastor, S.; Rodriguez, A.; Artola, A. Symptomatic dry eye treatment with autologous platelet-rich plasma. Ophthalmic. Res., 2007, 39(3), 124-129.
45. Murube, J.; Benitez del Castillo, J.M.; Chenzhuo, L.; Berta, A.; Rolando, M. The Madrid triple classification of dry eye. Arch. Soc. Esp. Oftalmol., 2003, 78(11), 595-601.
46. Yang, C.Q.; Sun, W.; Gu, Y.S. A clinical study of the efficacy of topical corticosteroids on dry eye. J. Zhejiang Univ. Sci. B., 2006, 7(8), 675-678.
47. Wilson, S.E.; Ambrosio, R. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. Am. J. Ophthalmol., 2001, 132(3), 405-406.
48. Holly F.J. Physical chemistry of the normal and disordered tear film. Trans. Ophthalmol. Soc. UK, 1985, 104(Pt 4), 374-380.
49. Ambrosio R. Jr.; Tervo, T.; Wilson, S.E. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg., 2008, 24(4), 396-407.
50. Pâques, M.; Chastang, C.; Mathis, A.; Sahel, J.; Massin, P.; Dosquet, C.; Korobelnik, J.F.; Le Gargasson, J.F.; Gaudric, A. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicenter, double-masked, randomized trial. Platelets in Macular Hole Surgery Group. Ophthalmology, 1999, 106(5), 932-938.